Hugo Mathers
Reporter
Hugo joined Capital Brief after five years in government roles across London and Sydney. He also previously worked in venture capital with Europe's first proptech VC fund Pi Labs and edtech startup Primo Toys, and has written for Time Out, Urban List and The Mandarin.
Contact Hugo via email.
Chief executive Todd Barlow says the famously long-term investor is adopting a more dynamic approach in response to turbulent global markets.
A “not financially material” contract with the influential Mayo Clinic triggered another surge in the medtech’s share price. Naysayers are starting to doubt themselves.
The cloud software group said booming customer demand has led it to open a second Australian office and fire up a recruitment drive as its local SaaS peers scale back.
The peak body for the local data centre industry has pushed back against the government’s “strange” data centre plan, which will require hyperscalers to contribute to the energy transition.
Market watchers say trading uncertainty and depleted valuations have left the door open for opportunistic buyers.
The dual-listed critical minerals company is drawing fresh short interest after a major accounting correction wiped more than a fifth off its share price on Tuesday.
The WiFi technology company has enlisted Joe Bedewi for his public markets credentials as it lays the groundwork for a long-awaited ASX listing.
The surging defence stock has emulated DroneShield again, and not in a good way, with a CEO selldown to pay for a house and divorce triggering a 17% plunge in less than an hour.
US-based Superpower is licensing Australian nasal spray technology from an ASX-listed biotech, and funding clinical research Big Pharma won’t touch.
Fresh from a surprise Nasdaq IPO, Sharon AI is pressing ahead with plans for a rapid ASX listing while ramping up AI compute capacity in Melbourne.
Titanium mining and alloy business IperionX’s shares have tanked more than 40% since the release of its half-year accounts on Thursday.
